Jhanina Campos Tineo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jhanina Campos Tineo has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Ariana Alessandra Córdova Salazar
Institute of Biomedical Sciences Research, Ricardo Palma University, Lima 15039, Peru
1 shared publication Universidad Ricardo Palma. Lima Instituto de Investigaciones En Ciencias Biomédicas
1 shared publication- Yudith Cauna Orocollo
Instituto de Investigaciones en ciencias biomédicas, Universidad Ricardo Palma
1 shared publication
Latest Publications
- Open Access
- 30 November 2023
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 23 (4) , 150-157
MURINE MODELS FOR THE STUDY OF TRIPLE NEGATIVE BREAST CANCER
The study of different variables, such as pathogenesis, inflammatory profile, identification of therapeutic targets, efficacy of treatments in murine models has proven to be one of the most practical for the preclinical study of triple negative breast cancer (TNBC), the most aggressive subtype of cancer, with limited application of treatments and low survival rate. However, it must be recognized that there are other minors in which the induction of TNBC is being standardized. This review encompasses the different induction methods that have allowed the development of TNBC and the most relevant therapeutic applications by which murine models with TNBC were developed.
- 30 November 2023
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 23 (4) , 150-157
Open AccessMURINE MODELS FOR THE STUDY OF TRIPLE NEGATIVE BREAST CANCER
The study of different variables, such as pathogenesis, inflammatory profile, identification of therapeutic targets, efficacy of treatments in murine models has proven to be one of the most practical for the preclinical study of triple negative breast cancer (TNBC), the most aggressive subtype of cancer, with limited application of treatments and low survival rate. However, it must be recognized that there are other minors in which the induction of TNBC is being standardized. This review encompasses the different induction methods that have allowed the development of TNBC and the most relevant therapeutic applications by which murine models with TNBC were developed.